Log In
BCIQ
Print this Print this
 

C-Cure, C3BS-CQR-1

  Manage Alerts
Collapse Summary General Information
Company Celyad S.A.
DescriptionCellular therapy based on autologous stem cells differentiated into cardiac precursors called cardiopoietic cells
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$49.4M

$27.1M

0


 Deals Details
Get a free BioCentury trial today